论文部分内容阅读
本文报道对血源性乙型肝炎疫苗低应答或无应答者接种酵母重组疫苗后的抗-HBs应答情况,并鉴定了无应答者的人白细胞抗原(HLA)亚型特征。作者从740名接种3或4剂血源性乙型肝炎疫苗者中筛选出25名低应答或无应答者,按0、1和6个月接种3次酵母重组乙型肝炎疫苗,每次于三角肌注射1ml含10μgHBsAg的疫苗。然后分别于0、1、2、3、6、8、12和18个月采血检测抗-HBs。结果9人(36%)无应答〔S/N≤2.1样本比率单位
This article reports the response of anti-HBs following vaccination of yeast recombinant vaccines against low or no Hepatitis B vaccine in Hepatitis B patients and identifies HLA subtypes of non-responders. The authors screened out 25 of the 740 low- or no-responders who had been vaccinated with 3 or 4 doses of blood-borne hepatitis B vaccine and inoculated 3 yeast recombinant hepatitis B vaccines at 0, 1, and 6 months, each at Deltoid injected 1ml vaccine containing 10μg HBsAg. Blood samples were then tested for anti-HBs at 0, 1, 2, 3, 6, 8, 12, and 18 months. Results 9 (36%) had no response (S / N ≤ 2.1 sample rate units